Chemed Price to Sales Ratio 2010-2025 | CHE

Historical PS ratio values for Chemed (CHE) over the last 10 years. The current P/S ratio for Chemed as of May 13, 2025 is . For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Chemed P/S Ratio Historical Data
Date Stock Price TTM Sales per Share Price to Sales Ratio
2025-05-13 557.17 3.38
2025-03-31 615.32 $165.00 3.73
2024-12-31 529.32 $159.59 3.32
2024-09-30 599.88 $156.00 3.85
2024-06-30 541.13 $153.17 3.53
2024-03-31 639.74 $150.49 4.25
2023-12-31 582.37 $149.15 3.90
2023-09-30 517.22 $146.81 3.52
2023-06-30 538.67 $144.67 3.72
2023-03-31 534.39 $143.44 3.73
2022-12-31 506.87 $141.29 3.59
2022-09-30 433.18 $139.02 3.12
2022-06-30 465.39 $138.03 3.37
2022-03-31 501.86 $135.93 3.69
2021-12-31 523.73 $133.34 3.93
2021-09-30 460.12 $131.91 3.49
2021-06-30 469.03 $130.18 3.60
2021-03-31 454.21 $127.79 3.55
2020-12-31 525.71 $126.69 4.15
2020-09-30 473.79 $125.77 3.77
2020-06-30 444.61 $122.54 3.63
2020-03-31 426.72 $120.66 3.54
2019-12-31 432.37 $117.39 3.68
2019-09-30 410.70 $113.01 3.63
2019-06-30 354.64 $110.46 3.21
2019-03-31 314.28 $107.95 2.91
2018-12-31 277.91 $106.00 2.62
2018-09-30 313.23 $104.36 3.00
2018-06-30 315.11 $102.91 3.06
2018-03-31 266.95 $102.55 2.60
2017-12-31 237.50 $100.70 2.36
2017-09-30 197.22 $99.15 1.99
2017-06-30 199.36 $97.82 2.04
2017-03-31 177.84 $95.09 1.87
2016-12-31 155.92 $93.67 1.66
2016-09-30 136.86 $92.52 1.48
2016-06-30 132.00 $90.98 1.45
2016-03-31 130.92 $89.71 1.46
2015-12-31 144.52 $88.54 1.63
2015-09-30 128.56 $86.93 1.48
2015-06-30 126.08 $85.09 1.48
2015-03-31 114.62 $83.31 1.38
2014-12-31 101.25 $81.32 1.25
2014-09-30 98.39 $78.81 1.25
2014-06-30 89.42 $76.88 1.16
2014-03-31 85.16 $75.57 1.13
2013-12-31 72.77 $75.29 0.97
2013-09-30 67.73 $75.59 0.90
2013-06-30 68.42 $75.45 0.91
2013-03-31 75.35 $74.90 1.01
2012-12-31 64.47 $73.84 0.87
2012-09-30 64.94 $71.51 0.91
2012-06-30 56.48 $69.46 0.81
2012-03-31 58.41 $66.58 0.88
2011-12-31 47.60 $63.69 0.75
2011-09-30 50.94 $61.57 0.83
2011-06-30 60.56 $59.29 1.02
2011-03-31 61.44 $57.53 1.07
2010-12-31 58.45 $55.60 1.05
2010-09-30 52.31 $54.33 0.96
2010-06-30 50.03 $53.45 0.94
2010-03-31 49.69 $52.82 0.94
2009-12-31 43.74 $52.43 0.83
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $8.326B $2.431B
Chemed Corporation purchases, operates and divests subsidiaries engaged in diverse business activities. The company's operating businesses are managed on a decentralized basis. Chemed currently operates as two wholly-owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS Healthcare segment provides hospice and palliative care services for patients with terminal illnesses. VITAS offer all levels of hospice care in a given market, including routine home care, inpatient care and continuous care. Roto-Rooter segment provides plumbing and drain-cleaning services to both residential and commercial customers. It provides repair and maintenance services to residential and commercial accounts using the Roto-Rooter registered service marks. Such services include plumbing and sewer, drain and pipe cleaning. They are delivered through company-owned and operated territories, independent contractor-operated territories and franchised locations.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $19.637B 19.35
Encompass Health (EHC) United States $11.786B 24.99
DaVita (DVA) United States $11.101B 15.33
Elanco Animal Health (ELAN) United States $6.367B 13.64
Option Care Health (OPCH) United States $5.217B 23.25
RadNet (RDNT) United States $4.278B 271.57
Amedisys (AMED) United States $3.132B 21.06
LifeStance Health (LFST) United States $2.275B 0.00
Addus HomeCare (ADUS) United States $2.034B 22.33
Astrana Health (ASTH) United States $1.600B 39.64
U.S Physical Therapy (USPH) United States $1.175B 30.33
Aveanna Healthcare Holdings (AVAH) United States $1.128B 64.22
Pennant (PNTG) United States $1.019B 37.40
Atai Life Sciences (ATAI) Germany $0.288B 0.00
Daxor (DXR) United States $0.035B 0.00
Ontrak (OTRK) United States $0.007B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.005B 0.00
Psychemedics (PMD) United States $0.000B 0.00